X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (31) 31
humans (26) 26
anakinra (17) 17
rheumatology (16) 16
canakinumab (14) 14
male (14) 14
familial mediterranean fever (13) 13
anti-il-1 treatment (11) 11
colchicine (11) 11
animals (10) 10
anti-il-1 (10) 10
antibodies, monoclonal - therapeutic use (10) 10
inflammation (10) 10
female (9) 9
immunology (9) 9
interleukin 1 receptor antagonist protein - therapeutic use (9) 9
interleukin-1 - antagonists & inhibitors (9) 9
adult (8) 8
amyloidosis (8) 8
colchicine - therapeutic use (8) 8
cytokines (8) 8
efficacy (8) 8
familial mediterranean fever - drug therapy (8) 8
interleukin-1 (8) 8
double-blind (7) 7
mutation (7) 7
treatment outcome (7) 7
autoinflammatory diseases (6) 6
children (6) 6
il-1 (6) 6
pharmacology & pharmacy (6) 6
safety (6) 6
arthritis (5) 5
colchicine-resistant (5) 5
interleukin 1 (5) 5
interleukin 1 receptor antagonist (5) 5
mice (5) 5
rilonacept (5) 5
abridged index medicus (4) 4
activation (4) 4
anti-il-1 therapy (4) 4
anti-il-1β (4) 4
child (4) 4
dermatology (4) 4
disease (4) 4
genetic aspects (4) 4
gout suppressants - therapeutic use (4) 4
il-1β (4) 4
interleukin-1 - metabolism (4) 4
interleukin-1 receptor antagonist (4) 4
interleukins (4) 4
internal medicine (4) 4
medicine & public health (4) 4
middle aged (4) 4
quality-of-life (4) 4
rheumatoid-arthritis (4) 4
therapy (4) 4
adolescent (3) 3
anti-il-1 antibody (3) 3
anti-il-1 beta (3) 3
anti-il-1 beta therapy (3) 3
anti-il-1β therapy (3) 3
anti-inflammatory agents, non-steroidal - therapeutic use (3) 3
antibodies, monoclonal - adverse effects (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
antirheumatic agents - therapeutic use (3) 3
autoimmune diseases (3) 3
autoinflammatory disease (3) 3
care and treatment (3) 3
drug resistance (3) 3
fever (3) 3
il-1 receptor antagonist (3) 3
immunologic factors - pharmacology (3) 3
inflammation - drug therapy (3) 3
inflammatory diseases (3) 3
infliximab (3) 3
interleukin (3) 3
interleukin 1 receptor antagonist protein (3) 3
interleukin-1 - physiology (3) 3
macrophage activation syndrome (3) 3
mefv mutations (3) 3
monoclonal antibodies (3) 3
of-the-literature (3) 3
pathogenesis (3) 3
patient (3) 3
patients (3) 3
proteinuria (3) 3
pyrin (3) 3
quality of life (3) 3
receptor antagonist (3) 3
recombinant fusion proteins - therapeutic use (3) 3
review (3) 3
spions (3) 3
systemic juvenile idiopathic arthritis (3) 3
targeting therapy (3) 3
temporal lobe epilepsy (3) 3
tolerance (3) 3
tumor-necrosis-factor (3) 3
acne vulgaris - drug therapy (2) 2
acne vulgaris - pathology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arthritis Care & Research, ISSN 2151-464X, 07/2018, Volume 70, Issue 7, pp. 1090 - 1094
Journal Article
Best Practice & Research: Clinical Rheumatology, ISSN 1521-6942, 2012, Volume 26, Issue 4, pp. 477 - 487
Journal Article
Expert Review of Clinical Immunology, ISSN 1744-666X, 05/2017, Volume 13, Issue 5, pp. 393 - 404
Introduction: Familial Mediterranean fever (FMF) is the most frequent of all hereditary autoinflammatory syndromes. It is characterized by recurrent attacks of... 
colchicine-resistant familial Mediterranean fever | hereditary periodic fever syndromes | familial Mediterranean fever | Canakinumab | IL-1β | Anti IL-1 drugs | INTERLEUKIN-1 | EFFICACY | IL-1 | SAFETY | OPEN-LABEL | ANTI-IL-1 TREATMENT | IMMUNOLOGY | CHILDREN | RILONACEPT | TREATMENT OPTIONS | DOUBLE-BLIND | COLCHICINE-RESISTANT
Journal Article
by Wang, YL and Sun, R and Wu, XR and Chu, X and Zhou, SH and Hu, XB and Gao, LY and Kong, QX
JOURNAL OF TRANSLATIONAL MEDICINE, ISSN 1479-5876, 12/2018, Volume 16, Issue 1, pp. 337 - 13
Background: Temporal lobe epilepsy (TLE) is a common and often refractory brain disease that is closely correlated with inflammation. Alpha-methyl-L-tryptophan... 
MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | SPIONs | FUNCTIONALIZED MAGNETONANOPARTICLES | Targeting location | Targeting therapy | AMT | RECEPTOR | BLOOD-BRAIN-BARRIER | ASTROCYTES | QUINOLINIC ACID | IN-VITRO | Anti-IL-1 beta-mAb | TRACER LOCALIZATION | MICROGLIA | Temporal lobe epilepsy | CONTRIBUTES | Inflammation - pathology | Acute Disease | Epilepsy, Temporal Lobe - drug therapy | Interleukin-1beta - immunology | Tryptophan - chemistry | Antibodies, Monoclonal - therapeutic use | Male | Glial Fibrillary Acidic Protein - metabolism | Rats, Sprague-Dawley | Magnetic Resonance Imaging | Magnetite Nanoparticles - chemistry | Animals | Transcription Factor RelA - metabolism | Tryptophan - analogs & derivatives | Epilepsy, Temporal Lobe - pathology | Neuroimaging | Drugs | Brain | Drug delivery systems | Nuclear magnetic resonance--NMR | Epilepsy | Medical services | Staining | Lithium | Pilocarpine | Iron | Drug delivery | Western blotting | Nanoparticles | Convulsions & seizures | Histopathology | Blood-brain barrier | L-Tryptophan | Localization | Brain diseases | Alpha iron | Medical research | Temporal lobe | Medical imaging | Cytokines | Neurons | Tryptophan | Inflammation | Perl | Metabolism | IL-1β | Brain research | Magnetic resonance imaging | Monoclonal antibodies | Ligands | Iron oxides | Magnetic fields | Molecular biology | Immunofluorescence | Anti-IL-1β-mAb
Journal Article
ZEITSCHRIFT FUR RHEUMATOLOGIE, ISSN 0340-1855, 02/2019, Volume 78, Issue 1, pp. 91 - 101
BackgroundFamilial Mediterranean fever (FMF) in Germany is a rare, genetically linked disease of childhood and adolescence, which is characterized by recurrent... 
Interleukin-1 | Fever attacks | PROTRACTED FEBRILE MYALGIA | DISEASE SEVERITY | SUBCLINICAL INFLAMMATION | ANTI-IL-1 TREATMENT | ANAKINRA | RHEUMATOLOGY | CHILDREN | TERM COLCHICINE PROPHYLAXIS | Biologics | Amyloidosis | Colchicine | QUALITY-OF-LIFE | HETEROZYGOUS CARRIERS | MEFV MUTATIONS
Journal Article
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 08/2016, Volume 9, Issue 8, pp. 1015 - 1024
Introduction: Canakinumab, a fully human monoclonal antibody against interleukin-1β, is a relatively new medication approved for treatment of systemic juvenile... 
canakinumab | anti-IL-1β | Systemic juvenile idiopathic arthritis | biologic | systemic JIA | SJIA | monoclonal antibody | mAb | MULTICENTER | EFFICACY | SAFETY | ANAKINRA | TOCILIZUMAB | PATHOGENESIS | TRIAL | anti-IL-1 beta | MACROPHAGE ACTIVATION SYNDROME | PHARMACOLOGY & PHARMACY
Journal Article
Current Treatment Options in Rheumatology, ISSN 2198-6002, 12/2016, Volume 2, Issue 4, pp. 283 - 295
Kawasaki disease (KD) is a multisystemic vasculitis affecting young children and the most common cause of acquired heart disease in children in the developed... 
Vasculitis | Kawasaki disease | Medicine & Public Health | Rheumatology | Biologic agents | Anti-TNF | Anti-IL-1
Journal Article
Expert Review of Clinical Immunology, ISSN 1744-666X, 11/2014, Volume 10, Issue 11, pp. 1427 - 1435
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 03/2017, Volume 8, p. 253
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 02/1994, Volume 95, Issue 2, pp. 237 - 243